सर्विक्स कैंसर
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
कहाँ जाना है
इस trial के लिए 3 hospital भारत में मरीज़ ले रहे हैं।
रजिस्ट्री समरी (तकनीकी)
Cervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable deaths annually. With high-risk human papillomavirus (HR-HPV) as the causative agent for CC, one risk factor that places women at high risk for CC is human immunodeficiency virus (HIV), as impaired immune response against Human papillomavirus (HPV) may result in persistent HR-HPV infection, a critical risk factor for progression of HPV-related cervical oncogenesis. Progression of precancerous lesions among women living with HIV (WLH) is…
प्रायोजक: University of California, Irvine
ClinicalTrials.gov पर NCT07209917
रजिस्ट्री में आखिरी बार 31 जुलाई 2026 को अपडेट हुआ · हमने 20 अक्टूबर 2026 को देखा